Patent 9872852 was granted and assigned to Bristol-Myers Squibb on January, 2018 by the United States Patent and Trademark Office.
Disclosed are compounds of Formula (I): (I). Also disclosed are methods of using such compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of virological diseases or disorders and cancer.